The global biomaterials market is predicted to reach more than $173 billion by 2022, growing at a 16 percent compound annual growth rate, according to a Market Research Engine report.
Biologics
More and more surgeons are beginning to talk about biologics, stem cells and regenerative medicine. Sameer Mathur, MD, an orthopedic surgeon, explains the future of stem cells in a sponsored article with WRAL.com.
Bert Mandelbaum, MD, described the evidence supporting orthobiologic treatments for torn anterior cruciate ligaments in a Medscape column.
Anika Therapeutics will showcase its Hyalofast cartilage repair scaffold at the 2019 International Cartilage Repair Society Summit in San Diego, Jan. 17-18.
Hughston Clinic of Columbus (Ga.) orthopedic surgeon Champ Baker Jr., MD, implemented Lipogems technology to help repair patients' damaged tissue.
Advertisement
SPR Therapeutics appointed Peter Staats, MD, to chief medical advisor.
'A new class of bio-integrative implants': Dr. Stuart Miller on orthobiologics and implant selection
Stuart Miller, MD, is an orthopedic surgeon at MedStar Union Memorial Hospital and assistant professor at Johns Hopkins University School of Medicine, both based in Baltimore.
Biogennix named Michael Roux as the orthobiologic company's new general manager.
The global platelet rich plasma market is expected to hit $400 million by 2023, growing at a 13.3 percent compound annual growth rate, according to a Qurate Business Intelligence report.
The global orthopedic biomaterials market is expected to grow at a 7 percent compound annual growth rate between 2018 and 2022, according to a Technavio report.